pdl.com is a domain that was created on 1994-03-04,making it 30 years ago. It has several subdomains, such as investor.pdl.com , among others.
Discover pdl.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 69.862 KB |
Page Load Time: 0.584293 Seconds |
Website IP Address: 69.63.134.11 |
BioPharma Diagnostics - Insights biopharmadiagnostics.mayoclinic.com |
Investor Relations :: Sutro Biopharma, Inc. (STRO) ir.sutrobio.com |
RedHill Biopharma - Home ir.redhillbio.com |
Pharmaceutical Conferences 2019 | Biopharma congress 2019 | World Pharmacy Conferences 2019 | Life S biologicalsciences.pharmaceuticalconferences.com |
Medical Device & Biopharma Careers from Medtechy jobs.medtechy.com |
Investor Relations | PDL BioPharma, Inc. investor.pdl.com |
Biopharma Awards biopharmaawards.imapac.com |
Home | PDL BioPharma, Inc. https://www.pdl.com/ |
Leadership | PDL BioPharma, Inc ... https://www.pdl.com/leadership |
Frequently Asked Questions | PDL BioPharma, Inc ... https://www.pdl.com/faqs |
Sitemap https://www.pdl.com/sitemap |
Investor Updates | PDL BioPharma, Inc. https://www.pdl.com/investor-updates |
Investor Relations | PDL BioPharma, Inc. https://www.pdl.com/investor-relations |
PDL BioPharma Completes Divestiture of the Noden Pharmaceutical ... https://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-completes-divestiture-noden-pharmaceutical |
PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets ... https://www.pdl.com/news-releases/news-release-details/pdl-biopharma-reports-2020-third-quarter-financial-results-and |
Stock Information | PDL BioPharma, Inc. https://investor.pdl.com/investor-relations/stock-information |
Press Releases | PDL BioPharma, Inc. https://www.pdl.com/investor-relations/press-releases |
MX pdl.com. 7200 IN MX 10 pdl-com.mail.protection.outlook.com. |
NS pdl.com. 7200 IN NS ns24.worldnic.com. |
TXT pdl.com. 3600 IN TXT v=spf1 ip4:166.78.232.248 ip4:71.92.169.18 include:spf.protection.outlook.com include:spf.emailsignatures365.com ~all |
SOA pdl.com. 3865 IN SOA NS23.WORLDNIC.com. namehost.WORLDNIC.com. 121053123 10800 3600 604800 3600 |
Date: Thu, 23 Apr 2020 12:52:46 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
Link: https://www.pdl.com/wp-json/; rel="https://api.w.org/", https://www.pdl.com/; rel=shortlink |
Expires: Thu, 23 Apr 2020 12:38:45 GMT |
X-Powered-By: WP Engine |
X-Cacheable: SHORT |
Cache-Control: max-age=600, must-revalidate |
X-Cache: HIT: 2 |
X-Cache-Group: normal |
CF-Cache-Status: DYNAMIC |
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" |
Server: cloudflare |
CF-RAY: 5887b93d8b92ed7f-SJC |
Content-Encoding: gzip |
cf-request-id: 0248b21a700000ed7f21ab3200000001 |
charset="utf-8"/ |
content="width=device-width, initial-scale=1, maximum-scale=1.0" name="viewport"/ |
content="PDL Biopharma" name="apple-mobile-web-app-title"/ |
content="PDL Biopharma" name="application-name"/ |
content="#005da8" name="msapplication-TileColor"/ |
content="#005da8" name="theme-color"/ |
content="en_US" property="og:locale" |
content="website" property="og:type" |
content="PDL Biopharma - PDL" property="og:title" |
content="https://www.pdl.com/" property="og:url" |
content="PDL" property="og:site_name" |
content="summary" name="twitter:card" |
content="PDL Biopharma - PDL" name="twitter:title"/ |
content="Powered by WPBakery Page Builder - drag and drop page builder for WordPress." name="generator"/ |
content="https://www.pdl.com/wp-content/uploads/2017/06/cropped-PDL_wordpress@2.67x-2-270x270.png" name="msapplication-TileImage"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
PDL Leadership Equity Investments Noden Pharma Products from Noden Pharma LENSAR LENSAR Product Alternative Financings Portfolio of Assets On-Going Transactions Concluded Transactions Investor Relations News Contact About PDL Leadership Equity Investments Noden Pharma Products from Noden Pharma LENSAR LENSAR Product Alternative Financings Portfolio of Assets On-Going Transactions Concluded Transactions Investor Relations News Contact PDL BioPharma seeks to provide a significant return for its shareholders by acquiring commercial stage pharmaceutical assets with multiple year revenue growth potential as well as late clinical stage pharmaceutical products. Company Presentations & Events Our Portfolio of Assets Our Subsidiaries RECENT NEWS PDL BioPharma, Inc. News Releases PDL BioPharma Reports 2019 Fourth Quarter and Full Year Financial Results and Announces Plan to Dissolve the Company by Year-End 2020 March 11, 2020 PDL BioPharma Announces Appointment of Edward A. Imbrogno as Vice President and Chief Financial Officer March 9, 2020 PDL BioPharma to Announce 2019 Fourth Quarter and Full Year Financial Results on March 11, 2020 March 4, 2020 CURRENT ALTERNATIVE INVESTMENTS CONCLUDED ALTERNATIVE INVESTMENTS Terms of Use Sitemap © Copyright 2020 PDL BioPHARMA. All Rights...
Domain Name: PDL.COM Registry Domain ID: 867_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2024-03-05T05:29:58Z Creation Date: 1994-03-04T05:00:00Z Registry Expiry Date: 2034-03-05T05:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS23.WORLDNIC.COM Name Server: NS24.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:43:59Z <<<